List view / Grid view
Two strengths for three-month administration of Lupron Depot-PED ® approved...
16 August 2011 | By Abbott
Two strengths for three-month administration of Lupron Depot-PED ® approved...
Biogen Idec and Abbott announced positive top-line results from SELECT,…
9 August 2011 | By Abbott
Biogen Idec and Abbott announced positive top-line results from SELECT, a global, registrational Phase 2b clinical trial...
"Lupron Depot is an important treatment option for many patients..."
20 June 2011 | By Abbott
"Lupron Depot is an important treatment option for many patients..."
The U.S. FDA approved an infant-specific dose of CREON® (pancrelipase)…
14 June 2011 | By Abbott
The U.S. FDA approved an infant-specific dose of CREON® (pancrelipase) Delayed-Release Capsules to treat EPI due to cystic fibrosis...
Results of the ACCORD Lipid study...
19 May 2011 | By Abbott
Results of the ACCORD Lipid study...
